Long‐Term Recurrence Rates in Previously Untreated (Primary) Basal Cell Carcinoma: Implications for Patient Follow‐Up

DAN E. ROWE , RAYMOND J. CARROLL , CALVIN L. JR. DAY
The Journal of Dermatologic Surgery and Oncology 15 ( 3) 315 -328

966
1989
A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease.

CALVIN L DAY , ARTHUR J. SOBER , ALFRED W. KOPF , ROBERT A. LEW
Annals of Surgery 193 ( 4) 436 -440

99
1981
The malignant potential of small congenital nevocellular nevi: an estimate of association based on a histologic study of 234 primary cutaneous melanomas

Arthur R Rhodes , Arthur J Sober , Calvin L Day , John W Melski
Journal of the American Academy of Dermatology 6 ( 2) 230 -241

273
1982
Skin lesions suspected to be melanoma should be photographed. Gross morphological features of primary melanoma associated with metastases

Calvin L Day , Martin C Mihm , Arthur J Sober , Thomas B Fitzpatrick
JAMA: The Journal of the American Medical Association 248 ( 9) 1077 -1081

4
1982
Multivariate analysis. Some guidelines for physicians

Robert A Lew , Calvin L Day , Terence J Harrist , William C Wood
JAMA: The Journal of the American Medical Association 249 ( 5) 641 -643

33
1983
Multivariate Analysis-Reply

Robert A Lew , Calvin L Day , Terence J Harrist , Martin C Mihm
JAMA: The Journal of the American Medical Association 250 ( 18) 2472 -2472

1
1983
218
1982
Prognosis in Stage 1 malignant melanoma: seven-year follow-up study of splenic radiocolloid uptake as predictor of death

Arthur J. Sober , Kenneth A. McKusick , Howard K. Koh , Alfred Kopf
The Journal of Nuclear Medicine 25 ( 11) 1183 -1189

4
1984
Eruptive widespread Spitz nevi

Steven A. Smith , Calvin L. Day , Darl E. Vander Ploeg
Journal of The American Academy of Dermatology 15 ( 5) 1155 -1159

36
1986
Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas

Arthur R. Rhodes , Terence J. Harrist , Calvin L. Day , Martin C. Mihm
Journal of The American Academy of Dermatology 9 ( 4) 563 -574

175
1983
Predictors of Late deaths among patients with clinical stage I melanoma who have not had bony or visceral metastases within the first 5 years after diagnosis

Calvin L. Day , Martin C. Mihm , Arthur J. Sober , Matthew N. Harris
Journal of The American Academy of Dermatology 8 ( 6) 864 -868

23
1983
Cigarette smoking and malignant melanoma. Prognostic implications.

Howard K. Koh , Arthur J. Sober , Thomas B. Fitzpatrick , Calvin L. Day
Cancer 53 ( 11) 2570 -2573

23
1984
“Microscopic satellites” are more highly associated with regional lymph node metastases than is primary melanoma thickness

Terence J. Harrist , Darrell S. Rigel , Calvin L. Day , Arthur J. Sober
Cancer 53 ( 10) 2183 -2187

123
1984
Expression of activation antigens by T cells infiltrating basal cell carcinomas.

Francisco J. Guillén , Calvin L. Day , George F. Murphy
Journal of Investigative Dermatology 85 ( 3) 203 -206

23
1985
A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent disease.

Calvin L. Day , Arthur J. Sober , Alfred W. Kopf , Robert A. Lew
American Journal of Surgery 142 ( 2) 247 -251

73
1981
Factors Associated with Death from Melanoma from 2 to 5 Years Following Diagnosis in Clinical Stage I Patients

Arthur J. Sober , Calvin L. Day , Thomas B. Fitzpatrick , Robert A. Lew
Journal of Investigative Dermatology 80 ( 1) S53 -S55

30
1983
Early Death from Clinical Stage I Melanoma

Arthur J. Sober , Calvin L. Day , Thomas B. Fitzpatrick , Robert A. Lew
Journal of Investigative Dermatology 80 ( 1) S50 -S52

29
1983
Guidelines of care for malignant melanoma

Lynn A. Drake , Roger I. Ceilley , Raymond L. Cornelison , William L. Dobes
Journal of The American Academy of Dermatology 28 ( 4) 638 -641

24
1993
Prognosis in malignant melanoma

Calvin L. Day , Arthur J. Sober , Thomas B. Fitzpatrick , Robert A. Lew
Journal of the American Academy of Dermatology 3 ( 5) 525 -526

8
1980